American Portfolios Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$359K Sell
7,216
-1,258
-15% -$67.4K 0.02% 775
2022
Q2
$472K Buy
8,474
+376
+5% +$20.9K 0.02% 682
2022
Q1
$450K Sell
8,098
-484
-6% -$24.8K 0.02% 781
2021
Q4
$481K Buy
8,582
+1,030
+14% +$55.8K 0.02% 757
2021
Q3
$363K Buy
7,552
+1,232
+19% +$59.6K 0.01% 856
2021
Q2
$265K Buy
6,320
+210
+3% +$8.14K 0.01% 985
2021
Q1
$206K Buy
6,110
+16
+0.3% +$570 0.01% 1007
2020
Q4
$213K Buy
6,094
+164
+3% +$5.67K 0.01% 862
2020
Q3
$206K Buy
5,930
+1,554
+36% +$51.8K 0.01% 781
2020
Q2
$143K Buy
4,376
+206
+5% +$6.57K 0.01% 863
2020
Q1
$126K Sell
4,170
-278
-6% -$8.28K 0.01% 814
2019
Q4
$129K Buy
4,448
+1,388
+45% +$38.4K 0.01% 928
2019
Q3
$79.1K Buy
3,060
+164
+6% +$4.15K 0.01% 1101
2019
Q2
$73.9K Buy
2,896
+20
+0.7% +$494 0.01% 1114
2019
Q1
$75.2K Buy
2,876
+424
+17% +$10.4K 0.01% 1009
2018
Q4
$56.5K Buy
2,452
+466
+23% +$10.4K 0.01% 961
2018
Q3
$46.8K Sell
1,986
-2,006
-50% -$49K 0.01% 1141
2018
Q2
$92.1K Sell
3,992
-3,260
-45% -$77.5K 0.01% 834
2018
Q1
$179K Buy
7,252
+1,394
+24% +$36.6K 0.03% 560
2017
Q4
$157K Buy
+5,858
New +$149K 0.02% 587

Other funds holding NVO

American Portfolios Advisors's NVO Position: Q3 2022 in Review

American Portfolios Advisors reduced its Novo Nordisk (NVO) stake by 15% in Q3 2022, selling an estimated $67.4K and leaving 7,216 shares worth $359K. The position accounts for 0.02% of the portfolio, ranked #775.

American Portfolios Advisors first reported a position in NVO in Q4 2017 and has held it in 20 quarters since. The position peaked at $481K in Q4 2021. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • American Portfolios Advisors held 7,216 shares of Novo Nordisk worth $359K as of Q3 2022.
  • American Portfolios Advisors sold 1,258 Novo Nordisk shares in Q3 2022, an estimated $67.4K.
  • Novo Nordisk made up 0.02% of American Portfolios Advisors's portfolio in Q3 2022, its #775 holding.
  • American Portfolios Advisors first reported a position in Novo Nordisk in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Novo Nordisk position peaked at $481K in Q4 2021.
  • 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.